Working… Menu

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03326921
Recruitment Status : Recruiting
First Posted : October 31, 2017
Last Update Posted : May 28, 2021
Alex's Lemonade Stand Foundation
National Cancer Institute (NCI)
The Leukemia and Lymphoma Society
HighPass Bio, Inc.
Information provided by (Responsible Party):
Fred Hutchinson Cancer Research Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 16, 2024
Estimated Study Completion Date : July 16, 2025